{"entity":{"type":"insider","cik":"0001651036","url":"/insider/0001651036","json_url":"/insider/0001651036.json","name":"Landsittel Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":11,"first":"2020-03-11","last":"2025-03-07","span_basis":"filed_date"},"name_variants":[{"name":"Landsittel Michael","source":"filing","n_filings":11,"first_seen":"2020-03-11","last_seen":"2025-03-07"}],"transactions":[{"id":5153687,"accession":"0001415889-25-007392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-007392","line_url":"/filing/0001415889-25-007392#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001651036","owner_name":"Landsittel Michael","owner_display_name":"Landsittel Michael","owner_url":"/insider/0001651036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5284.0,"shares_display":"5,284","price_per_share":88.8,"price_display":"88.80","price_state":"stated","total_value":469219.2,"total_display":"469,219.20","total_whole":"469,219","shares_owned_after":72924.0,"shares_owned_after_display":"72,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":2900366,"accession":"0001415889-24-021550","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-021550","line_url":"/filing/0001415889-24-021550#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001651036","owner_name":"Landsittel Michael","owner_display_name":"Landsittel Michael","owner_url":"/insider/0001651036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4409.0,"shares_display":"4,409","price_per_share":95.23,"price_display":"95.23","price_state":"stated","total_value":419869.07,"total_display":"419,869.07","total_whole":"419,869","shares_owned_after":67208.0,"shares_owned_after_display":"67,208","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-15","filed_date":"2024-08-19","scope":"insider"},{"id":2806262,"accession":"0001415889-24-013469","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-013469","line_url":"/filing/0001415889-24-013469","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001651036","owner_name":"Landsittel Michael","owner_display_name":"Landsittel Michael","owner_url":"/insider/0001651036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3850.0,"shares_display":"3,850","price_per_share":106.95388571428572,"price_display":"106.95","price_state":"stated","total_value":411772.46,"total_display":"411,772.46","total_whole":"411,772","shares_owned_after":72981.0,"shares_owned_after_display":"72,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-15","filed_date":"2024-05-17","scope":"insider","n_lines":2},{"id":2755046,"accession":"0001415889-24-012359","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-012359","line_url":"/filing/0001415889-24-012359#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001651036","owner_name":"Landsittel Michael","owner_display_name":"Landsittel Michael","owner_url":"/insider/0001651036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":105.0,"price_display":"105.00","price_state":"stated","total_value":1050000.0,"total_display":"1,050,000.00","total_whole":"1,050,000","shares_owned_after":47286.0,"shares_owned_after_display":"47,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-02","filed_date":"2024-05-06","scope":"insider"},{"id":3262125,"accession":"0001415889-24-009536","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-009536","line_url":"/filing/0001415889-24-009536#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001651036","owner_name":"Landsittel Michael","owner_display_name":"Landsittel Michael","owner_url":"/insider/0001651036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":95.0,"price_display":"95.00","price_state":"stated","total_value":475000.0,"total_display":"475,000.00","total_whole":"475,000","shares_owned_after":47286.0,"shares_owned_after_display":"47,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-28","filed_date":"2024-04-01","scope":"insider"},{"id":2601697,"accession":"0001415889-24-008593","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001415889-24-008593","line_url":"/filing/0001415889-24-008593","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001651036","owner_name":"Landsittel Michael","owner_display_name":"Landsittel Michael","owner_url":"/insider/0001651036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13734.0,"shares_display":"13,734","price_per_share":87.78259793213921,"price_display":"87.78","price_state":"stated","total_value":1205606.2,"total_display":"1,205,606.20","total_whole":"1,205,606","shares_owned_after":51391.0,"shares_owned_after_display":"51,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-15","filed_date":"2024-03-19","scope":"insider","n_lines":6},{"id":2100710,"accession":"0001415889-24-007557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-007557","line_url":"/filing/0001415889-24-007557#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001651036","owner_name":"Landsittel Michael","owner_display_name":"Landsittel Michael","owner_url":"/insider/0001651036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5003.0,"shares_display":"5,003","price_per_share":90.69,"price_display":"90.69","price_state":"stated","total_value":453722.07,"total_display":"453,722.07","total_whole":"453,722","shares_owned_after":56020.0,"shares_owned_after_display":"56,020","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-11","scope":"insider"},{"id":8383383,"accession":"0001415889-23-004557","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-004557","line_url":"/filing/0001415889-23-004557","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001651036","owner_name":"Landsittel Michael","owner_display_name":"Landsittel Michael","owner_url":"/insider/0001651036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3007.0,"shares_display":"3,007","price_per_share":45.68041237113402,"price_display":"45.68","price_state":"stated","total_value":137361.0,"total_display":"137,361.00","total_whole":"137,361","shares_owned_after":48619.0,"shares_owned_after_display":"48,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider","n_lines":2},{"id":6286724,"accession":"0001415889-22-002735","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-002735","line_url":"/filing/0001415889-22-002735#line-2","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001651036","owner_name":"Landsittel Michael","owner_display_name":"Landsittel Michael","owner_url":"/insider/0001651036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1047.0,"shares_display":"1,047","price_per_share":56.19,"price_display":"56.19","price_state":"stated","total_value":58830.93,"total_display":"58,830.93","total_whole":"58,831","shares_owned_after":39030.0,"shares_owned_after_display":"39,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-08","scope":"insider"},{"id":6286718,"accession":"0001415889-22-002735","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-002735","line_url":"/filing/0001415889-22-002735#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001651036","owner_name":"Landsittel Michael","owner_display_name":"Landsittel Michael","owner_url":"/insider/0001651036","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1328.0,"shares_display":"1,328","price_per_share":60.27,"price_display":"60.27","price_state":"stated","total_value":80038.56,"total_display":"80,038.56","total_whole":"80,039","shares_owned_after":40077.0,"shares_owned_after_display":"40,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-08","scope":"insider"},{"id":5356114,"accession":"0001179110-21-003010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-003010","line_url":"/filing/0001179110-21-003010","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001651036","owner_name":"Landsittel Michael","owner_display_name":"Landsittel Michael","owner_url":"/insider/0001651036","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1507.0,"shares_display":"1,507","price_per_share":86.76097544790976,"price_display":"86.76","price_state":"stated","total_value":130748.79,"total_display":"130,748.79","total_whole":"130,749","shares_owned_after":28905.0,"shares_owned_after_display":"28,905","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-04","filed_date":"2021-03-05","scope":"insider","n_lines":2},{"id":3053283,"accession":"0001179110-20-003472","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-003472","line_url":"/filing/0001179110-20-003472#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001651036","owner_name":"Landsittel Michael","owner_display_name":"Landsittel Michael","owner_url":"/insider/0001651036","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":51.97,"price_display":"51.97","price_state":"stated","total_value":20788.0,"total_display":"20,788.00","total_whole":"20,788","shares_owned_after":17350.0,"shares_owned_after_display":"17,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-09","filed_date":"2020-03-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001597264","name":"Blueprint Medicines Corp","url":"/issuer/0001597264","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":11,"first_seen":"2020-03-11","last_seen":"2025-03-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001651036","retrieved_at":"2026-08-27T05:21:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}